Pulmonary Nodule Management: A Narrative Review of Clinical Decision-Making and Continuity of Care
Management of pulmonary nodules detected on computed tomography requires assessment of malignancy risk, treatment suitability and the benefits and harms of available options. This narrative review examines clinical decision-making and continuity of care for screening-detected and incidental nodules. Core searches of PubMed/MEDLINE, Embase, Web of Science and the Cochrane Library covered English-language literature from 2010 through August 2026, supplemented by targeted searches and citation tracing. Evidence was selectively synthesized around management decisions. Nodule type, prior imaging and consistent measurement methods guide risk assessment and surveillance. Surveillance intervals and intervention criteria remain specific to the detection setting, the nodule type and the applicable management framework. Further testing is appropriate when its results could change a feasible management plan; negative or nondiagnostic results require interpretation in light of residual malignancy risk. Treatment selection should balance expected benefit against procedural harm and overtreatment, considering cardiopulmonary reserve, frailty, comorbidity, competing mortality risks and patient preferences. Within the reviewed literature, patient-outcome benefit from artificial intelligence has not been established. Continuity of care requires completion of planned actions, review and communication of results, and clear responsibility for subsequent follow-up. Risk-informed decisions should be linked to reliable follow-up, with reassessment as imaging findings or patient circumstances change.
Authors
- Lei Xue (ORCID: https://orcid.org/0000-0002-3739-9778)
- Yueming Peng
- Qiang Yang
- Degang Liu
- Jun Li
- Jiangzhou Peng
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-13
- DOI
- https://doi.org/10.20944/preprints202611.1439.v1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- preprint